BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 34695841)

  • 1. Effect of Elective Internal Mammary Node Irradiation on Disease-Free Survival in Women With Node-Positive Breast Cancer: A Randomized Phase 3 Clinical Trial.
    Kim YB; Byun HK; Kim DY; Ahn SJ; Lee HS; Park W; Kim SS; Kim JH; Lee KC; Lee IJ; Kim WT; Shin HS; Kim K; Shin KH; Nam CM; Suh CO
    JAMA Oncol; 2022 Jan; 8(1):96-105. PubMed ID: 34695841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. POstmastectomy radioThErapy in Node-posiTive breast cancer with or without Internal mAmmary nodaL irradiation (POTENTIAL): a study protocol for a multicenter prospective phase III randomized controlled trial.
    Zhao XR; Fang H; Tang Y; Hu ZH; Jing H; Liang L; Yan XN; Song YW; Jin J; Liu YP; Chen B; Tang Y; Qi SN; Li N; Lu NN; Men K; Hu C; Zhang YH; Li YX; Wang SL
    BMC Cancer; 2021 Nov; 21(1):1185. PubMed ID: 34742270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Internal mammary node irradiation improves 8-year survival in breast cancer patients: results from a retrospective cohort study in real-world setting.
    Wang X; Luo J; Jin K; Chen X; Zhang L; Meng J; Zhang X; Zhang Z; Shao Z; Bazan JG; Guo X; Yang Z; Yu X
    Breast Cancer; 2020 Mar; 27(2):252-260. PubMed ID: 31696449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Internal mammary node irradiation in node-positive breast cancer treated with mastectomy and taxane-based chemotherapy.
    Cho WK; Chang JS; Park SG; Kim N; Choi DH; Kim H; Kim YB; Park W; Suh CO
    Breast; 2021 Oct; 59():37-43. PubMed ID: 34126377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term survival outcomes following internal mammary node irradiation in stage II-III breast cancer: results of a large retrospective study with 12-year follow-up.
    Chang JS; Park W; Kim YB; Lee IJ; Keum KC; Lee CG; Choi DH; Suh CO; Huh SJ
    Int J Radiat Oncol Biol Phys; 2013 Aug; 86(5):867-72. PubMed ID: 23747215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DBCG-IMN: A Population-Based Cohort Study on the Effect of Internal Mammary Node Irradiation in Early Node-Positive Breast Cancer.
    Thorsen LB; Offersen BV; Danø H; Berg M; Jensen I; Pedersen AN; Zimmermann SJ; Brodersen HJ; Overgaard M; Overgaard J
    J Clin Oncol; 2016 Feb; 34(4):314-20. PubMed ID: 26598752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of Internal Mammary Nodes is Associated With Improved Overall Survival in Breast Cancer: A Meta-Analysis.
    Shaikh PM; Mulherkar R; Khasawneh MT; Clump D; Hazard-Jenkins H; Hafez M; Vargo JA
    Am J Clin Oncol; 2024 Feb; 47(2):81-87. PubMed ID: 37916961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Internal Mammary Node Irradiation (IMNI) Improves Survival Outcome for Patients With Clinical Stage II-III Breast Cancer After Preoperative Systemic Therapy.
    Luo J; Jin K; Chen X; Wang X; Yang Z; Zhang L; Mei X; Ma J; Zhang X; Zhou Z; Wang X; Jiang Y; Shao Z; Zhang Z; Guo X; Yu X
    Int J Radiat Oncol Biol Phys; 2019 Mar; 103(4):895-904. PubMed ID: 30439485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IMNI PRECISION trial protocol: a phase II, open-label, non-inferior randomized controlled trial of tailoring omission of internal mammary node irradiation for early-stage breast cancer.
    Qi WX; Cao L; Zheng S; Xu C; Cai R; Xu H; Cai G; Chen J
    BMC Cancer; 2022 Dec; 22(1):1356. PubMed ID: 36575421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Internal mammary and medial supraclavicular lymph node chain irradiation in stage I-III breast cancer (EORTC 22922/10925): 15-year results of a randomised, phase 3 trial.
    Poortmans PM; Weltens C; Fortpied C; Kirkove C; Peignaux-Casasnovas K; Budach V; van der Leij F; Vonk E; Weidner N; Rivera S; van Tienhoven G; Fourquet A; Noel G; Valli M; Guckenberger M; Koiter E; Racadot S; Abdah-Bortnyak R; Van Limbergen EF; Engelen A; De Brouwer P; Struikmans H; Bartelink H;
    Lancet Oncol; 2020 Dec; 21(12):1602-1610. PubMed ID: 33152277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does internal mammary node irradiation affect treatment outcome in clinical stage II-III breast cancer patients receiving neoadjuv ant chemotherapy?
    Kim KH; Noh JM; Kim YB; Chang JS; Keum KC; Huh SJ; Choi DH; Park W; Suh CO
    Breast Cancer Res Treat; 2015 Aug; 152(3):589-99. PubMed ID: 26202053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Internal Mammary Node Irradiation in Patients With Node-Positive Early Breast Cancer: Fifteen-Year Results From the Danish Breast Cancer Group Internal Mammary Node Study.
    Thorsen LBJ; Overgaard J; Matthiessen LW; Berg M; Stenbygaard L; Pedersen AN; Nielsen MH; Overgaard M; Offersen BV;
    J Clin Oncol; 2022 Dec; 40(36):4198-4206. PubMed ID: 35394824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Internal Mammary and Medial Supraclavicular Irradiation in Breast Cancer.
    Poortmans PM; Collette S; Kirkove C; Van Limbergen E; Budach V; Struikmans H; Collette L; Fourquet A; Maingon P; Valli M; De Winter K; Marnitz S; Barillot I; Scandolaro L; Vonk E; Rodenhuis C; Marsiglia H; Weidner N; van Tienhoven G; Glanzmann C; Kuten A; Arriagada R; Bartelink H; Van den Bogaert W;
    N Engl J Med; 2015 Jul; 373(4):317-27. PubMed ID: 26200978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utilization patterns and temporal trends of internal mammary nodal irradiation at a tertiary cancer center.
    Misra S; Lee G; Maganti M; Koch CA
    Breast Cancer Res Treat; 2020 Jul; 182(2):367-379. PubMed ID: 32474745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and Safety of the Addition of Internal Mammary Irradiation to Standard Adjuvant Radiation in Early-Stage Breast Cancer: A Systematic Review and Meta-Analysis.
    Korzets Y; Levitas D; Grubstein A; Corn BW; Amir E; Goldvaser H
    Curr Oncol; 2022 Sep; 29(9):6657-6673. PubMed ID: 36135092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Axillary Dissection vs No Axillary Dissection on 10-Year Overall Survival Among Women With Invasive Breast Cancer and Sentinel Node Metastasis: The ACOSOG Z0011 (Alliance) Randomized Clinical Trial.
    Giuliano AE; Ballman KV; McCall L; Beitsch PD; Brennan MB; Kelemen PR; Ollila DW; Hansen NM; Whitworth PW; Blumencranz PW; Leitch AM; Saha S; Hunt KK; Morrow M
    JAMA; 2017 Sep; 318(10):918-926. PubMed ID: 28898379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can internal mammary lymph nodes irradiation bring survival benefits for breast cancer patients? A systematic review and meta-analysis of 12,705 patients in 12 studies.
    Jia S; Liu Z; Zhang J; Zhao C; Zhu L; Kong J; Han H; Shang Y; Shen D; Duan X
    Radiat Oncol; 2021 Feb; 16(1):42. PubMed ID: 33622345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Celecoxib vs Placebo as Adjuvant Therapy on Disease-Free Survival Among Patients With Breast Cancer: The REACT Randomized Clinical Trial.
    Coombes RC; Tovey H; Kilburn L; Mansi J; Palmieri C; Bartlett J; Hicks J; Makris A; Evans A; Loibl S; Denkert C; Murray E; Grieve R; Coleman R; Borley A; Schmidt M; Rautenberg B; Kunze CA; Rhein U; Mehta K; Mousa K; Dibble T; Lu XL; von Minckwitz G; Bliss JM;
    JAMA Oncol; 2021 Sep; 7(9):1291-1301. PubMed ID: 34264305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of Regional Nodal Irradiation for Breast Cancer Patients with Supraclavicular and/or Internal Mammary Lymph Node Involvement: A Multicenter, Retrospective Study (KROG 16-14).
    Kim K; Jeong Y; Shin KH; Kim JH; Ahn SD; Kim SS; Suh CO; Kim YB; Choi DH; Park W; Cha J; Chun M; Lee DS; Lee SY; Kim JH; Park HJ; Jung W
    Cancer Res Treat; 2019 Oct; 51(4):1500-1508. PubMed ID: 30913866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eight-year follow up result of the OTOASOR trial: The Optimal Treatment Of the Axilla - Surgery Or Radiotherapy after positive sentinel lymph node biopsy in early-stage breast cancer: A randomized, single centre, phase III, non-inferiority trial.
    Sávolt Á; Péley G; Polgár C; Udvarhelyi N; Rubovszky G; Kovács E; Győrffy B; Kásler M; Mátrai Z
    Eur J Surg Oncol; 2017 Apr; 43(4):672-679. PubMed ID: 28139362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.